Mustang Bio

MBIONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$4.168 M

$0.55 +1.91%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

-$1.92M

Loss-making

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#466Dermata TherapeuticsDRMA$4.63M
#467GRI BioGRI$4.24M
#468Mustang BioMBIO$4.17M
#469Sunshine BiopharmaSBFM$3.92M
#470Revelation BiosciencesREVB$3.89M

What if Mustang Bio were worth as much as…

Open the what-if tool →

Gold $30.3T

$3,995,253

Per share 7,264,097× higher

Bitcoin $1.72T

$226,961.73

Per share 412,658× higher

Nvidia $5.48T

$723,174.41

Per share 1,314,863× higher

Or at a round number

$10.0M $20.0M $50.0M $100.0M

Where these numbers come from

Share counts and financials for Mustang Bio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.